Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation

被引:10
|
作者
Liu, Jun [1 ]
Xia, Yu [1 ]
Zhang, Hao [1 ]
Li, Xiaofeng [1 ]
Zhang, Shu [1 ]
Fang, Pihua [1 ]
机构
[1] PUMC & CAMS, Fu Wai Hosp, Ctr Arrhythmia Diag & Treatment, Beijing, Peoples R China
关键词
Catheter ablation; Pulmonary vein isolation; Atrial flutter; Stroke; Bleeding;
D O I
10.1007/s00059-019-04880-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Cryoballoon ablation (CBA) is effective for patients with drug-refractory symptomatic atrial fibrillation (AF). For patients with a high risk of stroke (CHA(2)DS(2)-VASc score >= 2), life-long oral anticoagulation therapy should be continued even after successful catheter ablation. We investigated the safety and efficacy of concomitant use of a second-generation CBA catheter for pulmonary vein isolation (PVI) and a left atrial appendage closure (LAAC) device in patients with AF. Methods. We enrolled 27 patients (64.7 +/- 6.3 years, 74% male, 63% paroxysmal AF, 37% persistent AF, 4.8 +/- 1.4 CHA(2)DS(2)-VASc score, and 3.6 +/- 1.3 HAS-BLED score). In total, 85% of the patients had a prior stroke or TIA, and 30% of patients had a clinical history of bleeding. Patients received a CBA for PVI and underwent occlusion of the LAA with an LAAC device. The efficacy of CBA was defined as lack of arrhythmia recurrence (AF, atrial flutter, and/or atrial tachycardia lasting >= 30 s) after a 90-day blanking period. The success of LAAC was determined by the rate of stroke, TIA, and/or bleeding events. Results. The mean procedural time for CBA and LAAC was 80 +/- 16 min and 44 +/- 12 min, respectively. Acute PVI by CBA was achieved in 100% of the procedures, and 96% of patients obtained acute LAAC device placementduring the procedure. Upon complete release of the LAAC device, only 62% patients (16/26) had no detectable leakage during intraprocedural transesophageal echocardiography. Three patients experienced an acute complication: a pericardial effusion and two phrenic nerve palsy events. Mean follow-up was 18 months (range 9-23 months), and freedom from AF recurrence was 74% (20/27). Conclusion. The intraprocedural combination of CBA and LAAC is feasible in patients with non-valvular AF with a high risk of stroke, TIA, and/or bleeding. Larger long-term randomized studies are needed to judge the overall safety and efficacy of the combined procedure.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 50 条
  • [21] Editorial to "Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single-center experience of the left atrial appendage closure first strategy"
    Fukunaga, Masato
    JOURNAL OF ARRHYTHMIA, 2024, 40 (04) : 893 - 894
  • [22] Combined Radiofrequency Ablation and Left Atrial Appendage Closure in Atrial Fibrillation and Systolic Heart Failure
    Sun, Jian
    Zhang, Rui
    Yang, Mei
    Li, Wei
    Zhang, Peng-Pai
    Mo, Bin-Feng
    Wang, Qun-Shan
    Chen, Mu
    Li, Yi-Gang
    DIAGNOSTICS, 2023, 13 (21)
  • [23] 2019 Chinese expert consensus statement on left atrial appendage closure in patients with atrial fibrillation
    He Ben
    Ma Changsheng
    Wu Shulin
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2022, 45 (04): : 535 - 555
  • [24] Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation
    Wazni, Oussama
    Saliba, Walid
    Nair, Devi
    Marijon, Eloi
    Schmidt, Boris
    Hounshell, Troy
    Ebelt, Henning
    Skurk, Carsten
    Oza, Saumil
    Patel, Chinmay
    Kanagasundram, Arvindh
    Sadhu, Ashish
    Sundaram, Sri
    Osorio, Jose
    Mark, George
    Gupta, Madhukar
    Delurgio, David
    Olson, Jeff
    Nielsen-Kudsk, Jens Erik
    Boersma, Lucas
    Healey, Jeff
    Phillips, Karen
    Asch, Federico
    Roy, Kristine
    Christen, Thomas
    Sutton, Brad
    Stein, Kenneth
    Reddy, Vivek
    CIRCULATION, 2024, 150 (25) : E715 - E715
  • [25] Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices
    Wintgens, Lisette I. S.
    Klaver, Martijn N.
    Swaans, Martin J.
    Alipour, Arash
    Balt, Jippe C.
    van Dijk, Vincent F.
    Rensing, Benno J. W. M.
    Wijffels, Maurits C. E. F.
    Boersma, Lucas V. A.
    EUROPACE, 2019, 21 (03): : 428 - 433
  • [26] Left Atrial Appendage Closure Device in Atrial Fibrillation
    Giudici, Michael C.
    Bhave, Prashant D.
    CARDIOLOGY CLINICS, 2017, 35 (02) : 297 - +
  • [27] Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial
    Wazni, Oussama M.
    Boersma, Lucas
    Healey, Jeff S.
    Mansour, Moussa
    Tondo, Claudio
    Phillips, Karen
    Doshi, Rahul
    Jaber, Wael
    Hynes, Erin
    Allocco, Dominic J.
    Reddy, Vivek Y.
    AMERICAN HEART JOURNAL, 2022, 251 : 35 - 42
  • [28] Left atrial appendage closure in patients with intracranial haemorrhage and atrial fibrillation
    Fayos-Vidal, F.
    Arzamendi-Aizpurua, D.
    Millan-Alvarez, X.
    Guisado-Alonso, D.
    Camps-Renom, P.
    Prats-Sanchez, L.
    Martinez-Domeno, A.
    Delgado-Mederos, R.
    Marti-Fabregas, J.
    NEUROLOGIA, 2020, 35 (01): : 10 - 15
  • [29] Atrial fibrillation ablation in patients with known sludge in the left atrial appendage
    Hajjiri, Mohammed
    Bernstein, Scott
    Saric, Muhamed
    Benenstein, Ricardo
    Aizer, Anthony
    Dym, Glenn
    Fowler, Steven
    Holmes, Douglas
    Bernstein, Neil
    Mascarenhas, Mark
    Park, David
    Chinitz, Larry
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2014, 40 (02) : 147 - 151
  • [30] Hospital outcomes of patients receiving catheter ablation of atrial fibrillation, left atrial appendage closure, or both
    Ramez Morcos
    Haider Al Taii
    Muni Rubens
    Anshul Saxena
    Venkataraghavan Ramamoorthy
    Mohamed Hamed
    Amr F. Barakat
    Nitin Kulkarni
    Houman Khalili
    Santiago Garcia
    Michael Megaly
    Emir Veledar
    Stavros Stavrakis
    Journal of Interventional Cardiac Electrophysiology, 2023, 66 : 913 - 921